Please ensure Javascript is enabled for purposes of website accessibility

Intuitive Surgical Reports Significant COVID-19 Impact in Q1, Withdraws 2020 Guidance

By Keith Speights – Apr 8, 2020 at 2:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Significantly fewer procedures are now being done using its robotic surgical systems, and hospitals are postponing installation of new systems.

Intuitive Surgical (ISRG -1.83%) announced its preliminary first-quarter operational results on Wednesday and addressed the significant impact that the COVID-19 pandemic is having on its business. The robotic surgical systems company stated that the estimated number of procedures performed with its da Vinci system increased around 10% year over year in Q1. Intuitive reported that it shipped 237 da Vinci systems in the quarter, up slightly from the 235 systems shipped in the prior-year period. 

COVID-19 impact

Senior Director of Finance-Investor Relations Calvin Darling noted in the company's Q4 conference call in January that the first quarter tends to be the company's weakest because that's when patients' deductibles are reset for the year. However, the impact of the COVID-19 pandemic caused even bigger problems for the company in Q1.

Surgeons operating with a da Vinci robotic surgical system

Image source: Intuitive Surgical.

Intuitive Surgical disclosed in a regulatory filing on March 16 that its procedure volumes decreased in countries that had been impacted early by the novel coronavirus pandemic. On Wednesday, the company said that in the latter half of March, its procedure volume declined significantly in the U.S. and Western Europe, and there were delays in system placements in both regions.

Withdrawing full-year guidance

Because of the COVID-19 pandemic, Intuitive Surgical is withdrawing its 2020 financial and procedural guidance. The company anticipates that the global health crisis will continue to affect its operations and financial results significantly. But given the uncertainties about how long the pandemic will last and how long it will take for the global economy to recover, Intuitive Surgical can't estimate the extent of the impact this will have on its operations and financial results.

Keith Speights owns shares of Intuitive Surgical. The Motley Fool owns shares of and recommends Intuitive Surgical. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical Stock Quote
Intuitive Surgical
ISRG
$197.70 (-1.83%) $-3.68

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.